20.09.2012 - Pressure from governments to lower drug prices risks undermining medical innovation, Bayer's chief executive Marjin Dekkers said on Wednesday, echoing complaints of other drug...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
